Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans

Journal of Nuclear Medicine

Volumn 45, Issue 4, 2004, Pages 682-694

  Frankle, W Gordon ^a,b   Huang, Yiyun ^a   Hwang, Dah Ren ^a   Talbot, Peter S ^a   Slifstein, Mark ^a   Van Heertum, Ronald ^a   Abi Dargham, Anissa ^a   Laruelle, Marc ^a  

^a New York State Psychiatric Institute ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

11c (+) 6 (4 methylthiophenyl) 1,2,3,5,6 ,10 hexahydropyrrolo 2,1 a isoquinoline; 11c 3 amino 4 (2 dimethylaminomethylphenylthio)benzonitrile; PET; Serotonin transporter

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE C 11; 3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLTHIO)BENZONITRILE C 11; RADIOLIGAND; SEROTONIN TRANSPORTER; TRACER; UNCLASSIFIED DRUG; 1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; BENZYLAMINE DERIVATIVE; CARBON; CARRIER PROTEIN; DIAGNOSTIC AGENT; ISOQUINOLINE DERIVATIVE; MEMBRANE PROTEIN; N,N DIMETHYL 2 (2 AMINO 4 CYANOPHENYLTHIO)BENZYLAMINE; N,N-DIMETHYL-2-(2-AMINO-4-CYANOPHENYLTHIO)BENZYLAMINE; NERVE PROTEIN; RADIOPHARMACEUTICAL AGENT; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; BINDING SITE; BRAIN REGION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG UPTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ADOLESCENT; BLOOD; BRAIN; COMPARATIVE STUDY; METABOLIC CLEARANCE RATE; METABOLISM; SCINTISCANNING; TISSUE DISTRIBUTION; VALIDATION STUDY;

ADOLESCENT; ADULT; BENZYLAMINES; BRAIN; CARBON RADIOISOTOPES; CARRIER PROTEINS; FEMALE; HUMANS; ISOQUINOLINES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METABOLIC CLEARANCE RATE; NERVE TISSUE PROTEINS; RADIOPHARMACEUTICALS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TISSUE DISTRIBUTION;

EID: 2542492338     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 3H]paroxetine binding, a marker of serotonin uptake sites. Biol Psychiatry. 1988;24:299-309.
2. 3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res. 1989;486:261-268.
3. 3H-imipramine. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:61-72.
4. 11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET. Life Sci. 1993;53:883-892.
5. 11C]McN5652: a serotonin transporter radioligand. J Cereb Blood Flow Metab. 1999;19:967-981.
6. 11C](+)McN5652. Synapse. 1995;20:37-43.
7. 11C]McN 5652. J Nucl Med. 2000;41:1465-1477.
8. 11C](+)McN-5652: assessment of methods. J Cereb Blood Flow Metab. 2000;20:253-262.
9. 11C](+)McN5652. Biol Psychiatry. 2002;51:715-722.
10. 11C]McN 5652. Biol Psychiatry. 2003;54:1414-1421.
11. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA. Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings. Lancet. 1998;352:1433-1437.
12. Buchert R, Thomasius R, Nebeling B, et al. Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET. J Nucl Med. 2003;44:375-384.
13. 11C-labeled 2-(phenylthio)araalkylamines. J Med Chem. 2000;43:3103-3110.
14. Wilson AA, Houle S. Radiosynthesis of carbon-11 labelled N-methyl-2(arylthio) benzylamines: potential radiotracers for the serotonin reuptake receptor. J Labelled Compds Radiopharm. 1999;42:1277-1288.
15. 11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nucl Med Biol. 2002;29:509-515.
16. 11C]DASB. Eur J Nucl Med. 2000;27:1719-1722.
17. 11C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab. 2001;21:1342-1353.
18. 11C]AFM. J Cereb Blood Flow Metab. 2002;22:1377-1398.
19. 11C-DASB as serotonin transporter radioligands under various experimental conditions. J Nucl Med. 2002;43:678-692.
20. 11C]methionine. J Nucl Med. 1987;28:1037-1040.
21. 11C]McN-5652 from racemic McN-5652. J Labelled Compds Radiopharm. 1999;42:1301-1312.
22. Huang YY, Mahmood K, Simpson NR, Mason NS, Mathis CA. Stereoconservative synthesis of the enantiomerically pure precursors of [C-11](+)-McN 5652 and [C-11](-)-McN 5652. J Labelled Compds Radiopharm. 1998;41:9-17.
23. Mawlawi OM, Weiss R, Shinn A, Pidcock J, Slifstien M, Laruelle M. Performance characteristics of a head immobilization device for PET imaging [abstract]. J Nucl Med. 1999;40(suppl):281P.
24. 11C]NNC 756. Synapse. 1999;32:93-109.
25. Abi-Dargham A, Laruelle M, Seibyl J, et al. SPECT measurement of benzodiazepine receptors in human brain with [123-I]iomazenil: kinetic and equilibrium paradigms. J Nucl Med. 1994;35:228-238.
26. Gandelman MS, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB. Evaluation of ultrafiltration for the free fraction determination of single photon emission computerized tomography (SPECT) radiotracers: β-CIT, IBF and iomazenil. J Pharm Sci. 1994;83:1014-1019.
27. 11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab. 2000;20:225-243.
28. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr. 1992;16:620-633.
29. Duvernoy H. The Human Brain: Surface, Three-Dimensional Sectional Anatomy and MRI. New York, NY: Sringer-Verlag; 1991.
30. Talairach J, Tournoux P. Co-Planar Stereotactic Atlas of the Human Brain: Three-Dimensional Proportional System - An Approach of Cerebral Imaging. New York, NY: Theime Medical; 1988.
31. Killiany RJ, Moss MB, Nicholson T, Jolez F, Sandor T. An interactive procedure for extracting features of the brain from magnetic resonance images: the lobes. Human Brain Mapping. 1997;5:355-363.
32. Kates WR, Abrams MT, Kaufmann WE, Breiter SN, Reiss AL. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome. Psychiat Res Neuroimag. 1997;75:31-48.
33. Pani L, Gessa GL, Carboni S, Portas CM, Rossetti ZL. Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release? Eur J Pharmacol. 1990;180:85-90.
34. Mawlawi O, Martinez D, Slifstein M, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab. 2001;21:1034-1057.
35. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984;15:217-227.
36. 123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. I. Kinetic modeling of single bolus experiments. J Cereb Blood Flow Metab. 1994;14:439-452.
37. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab. 1991;11:735-744.
38. Levenberg K. A method for the solution of certain problems in least squares. Q Appl Math. 1944;2:164-168.
39. 2 receptors in healthy subjects. J Nucl Med. 1994;35:743-754.
40. 123I]b-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse. 1993;13:295-309.